BUZZ-U.S. STOCKS ON THE MOVE-United Natural Foods, Insmed, MacroGenics

Reuters
06-10
BUZZ-U.S. STOCKS ON THE MOVE-United Natural Foods, <a href="https://laohu8.com/S/INSM">Insmed</a>, MacroGenics

Eikon search string for individual stock moves: STXBZ

The Day Ahead newsletter: https://refini.tv/3LI4BU7

The Morning News Call newsletter: https://refini.tv/3dKUyB8

Wall street's main indexes were set for a slightly higher open on Tuesday as investors awaited the outcome of ongoing trade talks between the United States and China aimed at cooling a tariff dispute that has bruised global markets this year. .N

** Novo Nordisk A/S <NVO.N>:BUZZ - Shares rise after report on Parvus building stake nL8N3SD0CF

** TechTarget Inc <TTGT.O>:BUZZ - Falls after JP Morgan downgrade nL4N3SD0JU

** Unicycive Therapeutics Inc <UNCY.O>:BUZZ - Tumbles as FDA flags manufacturing issues with kidney disease drug nL4N3SD0NU

** Recursion Pharmaceuticals Inc <RXRX.O>:BUZZ - Climbs after 20% staff reduction nL4N3SD0OS

** J.M. Smucker Co <SJM.N>:BUZZ - Drops after downbeat annual earnings forecast nL6N3SD0II

** United Natural Foods Inc <UNFI.N>:BUZZ - Shares rise as Q3 results beat estimates nL6N3SD0IR

** Designer Brands Inc <DBI.N>:BUZZ - Falls after withdrawing annual forecasts nL6N3SD0IL

** Insmed Inc <INSM.O>:BUZZ - Soars as blood pressure drug succeeds in mid-stage trial nL4N3SD0QV

** Xometry Inc <XMTR.O>:BUZZ - Dips after $225 mln convertible bond offering priced nL6N3SD0JN

** MacroGenics Inc <MGNX.O>:BUZZ - Rises after partnership with Sagard for drug royalties nL6N3SD0K0

(Compiled by Rajarshi Roy and Sumit Saha in Bengaluru)

((Rajarshi.Roy@thomsonreuters.com))

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10